Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 481-490 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPAR{gamma}-Ligands
Stephan Goetze, Anne Bungenstock, Cornelia Czupalla, Friedrich Eilers, Philipp Stawowy, Ulrich Kintscher, Chantel Spencer-Hänsch, Kristof Graf, Bernd Nürnberg, Ronald E. Law, Eckart Fleck, and Michael Gräfe
Hypertension published September 23, 2002, doi:10.1161/01.HYP.0000035522.63647.D3 [Abstract]  

Scientific Contributions
Angiotensin II AT1 Receptor Antagonists Inhibit Platelet Adhesion and Aggregation by Nitric Oxide Release
Leszek Kalinowski, Tomasz Matys, Ewa Chabielska, Wlodzimierz Buczko, and Tadeusz Malinski
Hypertension published September 16, 2002, doi:10.1161/01.HYP.0000034745.98129.EC [Abstract]  

Letters to the Editor
Endothelin Antagonists and Hypertension: A Question of Dose? Response
Jane Goddard, David J. Webb, Paul Martin, and Henry Krum
Hypertension 2002;40: -2e; published online before print as doi:10.1161/01.HYP.0000028980.24709.68 [Full text]  

Scientific Contributions
Acute Antihypertrophic Actions of Bradykinin in the Rat Heart: Importance of Cyclic GMP
Anke C. Rosenkranz, Sally G. Hood, Robyn L. Woods, Gregory J. Dusting, and Rebecca H. Ritchie
Hypertension published August 26, 2002, doi:10.1161/01.HYP.0000032854.74042.CF [Abstract]  

Scientific Contributions
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
Henry Krum, Hector Nolly, Diane Workman, Weizhong He, Barbara Roniker, Scott Krause, and Kaffa Fakouhi
Hypertension 2002;40:117-123; published online before print as doi:10.1161/01.HYP.0000025146.19104.FE [Abstract] [Full text]  

Scientific Contributions
Rapid Effects of Aldosterone and Spironolactone in the Isolated Working Rat Heart
John C. Barbato, Patrick J. Mulrow, Joseph I. Shapiro, and Roberto Franco-Saenz
Hypertension 2002;40:130-135; published online before print as doi:10.1161/01.HYP.0000025879.29822.24 [Abstract] [Full text]  

Scientific Contributions
N-Acetyl-Ser-Asp-Lys-Pro Inhibits Phosphorylation of Smad2 in Cardiac Fibroblasts
Saraswati Pokharel, Saman Rasoul, Anton J.M. Roks, Rick E.W. van Leeuwen, Marja J.A. van Luyn, Leo E. Deelman, Jos F. Smits, Oscar Carretero, Wiek H. van Gilst, and Yigal M. Pinto
Hypertension 2002;40:155-161; published online before print as doi:10.1161/01.HYP.0000025880.56816.FA [Abstract] [Full text]  

Scientific Contributions
Endogenous Endothelin-1 Limits Exercise-Induced Vasodilation in Hypertensive Humans
Carmel M. McEniery, Ian B. Wilkinson, David G. Jenkins, and David J. Webb
Hypertension 2002;40:202-206; published online before print as doi:10.1161/01.HYP.0000024218.04872.F3 [Abstract] [Full text]  

Scientific Contributions
N-Acetyl-Ser-Asp-Lys-Pro Inhibits Phosphorylation of Smad2 in Cardiac Fibroblasts
Saraswati Pokharel, Saman Rasoul, Anton J.M. Roks, Rick E.W. van Leeuwen, Marja J.A. van Luyn, Leo E. Deelman, Jos F. Smits, Oscar Carretero, Wiek H. van Gilst, and Yigal M. Pinto
Hypertension published July 1, 2002, doi:10.1161/01.HYP.0000025880.56816.FA [Abstract]  

Scientific Contributions
Rapid Effects of Aldosterone and Spironolactone in the Isolated Working Rat Heart
John C. Barbato, Patrick J. Mulrow, Joseph I. Shapiro, and Roberto Franco-Saenz
Hypertension published July 1, 2002, doi:10.1161/01.HYP.0000025879.29822.24 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment